Mary Ann Liebert: Using Cannabinoids to Treat Acute Pain
March 24, 2020
March 24, 2020
NEW ROCHELLE, New York, March 24 -- Mary Ann Liebert Inc. issued the following news release:
A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain. No increase in serious adverse events suggested the safety of using cannabinoids to treat acute pain, according to the study published in Cannabis and Cannabinoid Research, a peer-reviewed journal from . . .
A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain. No increase in serious adverse events suggested the safety of using cannabinoids to treat acute pain, according to the study published in Cannabis and Cannabinoid Research, a peer-reviewed journal from . . .